Evidence map›Paper›PMID 36985525›Full record

ReviewMolecules (Basel, Switzerland)2023

Metal Sulfide Nanoparticles for Imaging and Phototherapeutic Applications.

Aishwarya Shetty, Heinrich Lang, Sudeshna Chandra

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed.

  1. Review
  2. Phenylboronic acid modified AgRSC advances · 2026
    Article
  3. Article
  4. Review
  5. Review
  6. Review
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Aishwarya ShettyJournal of Visualized Experiments 625, Massachusetts Avenue, Cambridge, MA 02139, USA.
Heinrich LangChemnitz Research Group Organometallics, MAIN Research Center, Technische Universität, Rosenbergstr. 6, 09126 Chemnitz, Germany.
Sudeshna ChandraInstitute of Analytical Chemistry, University of Regensburg, 93040 Regensburg, Germany.ORCID 0000-0002-6565-9776

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The intriguing properties of metal sulfide nanoparticles (=MxSy-NPs), particularly transition metal dichalcogenides, are discussed for their use in diverse biological applications. Herein, recent advances in MxSy-NPs-based imaging (MRI, CT, optical and photoacoustic) and phototherapy (photothermal and photodynamic) are presented. Also, recent made progress in the use of immuno-phototherapy combinatorial approaches in vitro and in vivo are reported. Furthermore, challenges in nanomaterials-based therapies and future research directions by applying MxSy-NPs in combinatorial therapies are envisaged.

Indexed as

Metal NanoparticlesNanoparticlesNeoplasmsDiagnostic ImagingHumansPhototherapySulfidesSulfidesbioimagingimmunotherapymetal sulfide nanoparticlesphotodynamic therapyphotothermal therapy

Identifiers

PMID36985525
PMCPMC10051882

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.